Suppr超能文献

加拿大安大略省多伦多一家转诊中心2010 - 2016年耐多药结核病的危险因素

Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010-2016.

作者信息

Hirama Takashi, Sabur Natasha, Derkach Peter, McNamee Jane, Song Howard, Marras Theodore, Brode Sarah

机构信息

Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON.

Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, ON.

出版信息

Can Commun Dis Rep. 2020 Apr 2;46(4):84-92. doi: 10.14745/ccdr.v46i04a05.

Abstract

BACKGROUND

Drug-resistant tuberculosis (TB) poses a major public health concern worldwide. However, no studies have addressed risk factors for drug resistance in Ontario, which has its own unique profile of immigrants. We evaluated demographic and clinical risk factors for drug-resistant TB among patients treated at West Park Healthcare Centre, located in Toronto, Ontario (Canada).

METHODS

All patients who were diagnosed with TB and treated at West Park Healthcare Centre between January 2010 and December 2016 were included in this retrospective cohort study. Characteristics of patients with isoniazid mono-resistant (INH-R) TB and multidrug resistant (MDR) TB were compared to patients with drug-susceptible TB with bivariate and multivariable logistic regression.

RESULTS

Risk factors for INH-R TB included younger age (younger than 35 years), prior TB treatment, non-diabetic and birth in a non-South-East Asian country, but only the latter two factors were significant in multivariable analysis. On the other hand, we found younger generation (younger than 65 years), birth in European region, recent arrival to Canada (fewer than 120 months), prior treatment and human immunodeficiency virus (HIV) infection were associated with MDR-TB, among which younger age (younger than 35 years), more recent immigration (fewer than 24 months), prior treatment and HIV infection were significant in multivariable analysis.

CONCLUSION

These findings may be of use to TB clinicians in the province by informing the initial empiric antibiotic regimen prescribed while awaiting phenotypic drug susceptibility testing and assisting in decisions regarding whether to request rapid molecular drug susceptibility testing.

摘要

背景

耐多药结核病在全球范围内构成重大公共卫生问题。然而,安大略省拥有其独特的移民情况,尚无研究探讨该省耐多药结核病的危险因素。我们评估了位于加拿大安大略省多伦多市的西公园医疗中心接受治疗的患者中耐多药结核病的人口统计学和临床危险因素。

方法

本回顾性队列研究纳入了2010年1月至2016年12月期间在西公园医疗中心被诊断为结核病并接受治疗的所有患者。通过双变量和多变量逻辑回归,将异烟肼单耐药(INH-R)结核病和耐多药(MDR)结核病患者的特征与药物敏感结核病患者进行比较。

结果

INH-R结核病的危险因素包括年龄较小(35岁以下)、既往结核病治疗史、非糖尿病以及出生于非东南亚国家,但在多变量分析中只有后两个因素具有统计学意义。另一方面,我们发现年轻一代(65岁以下)、出生于欧洲地区、近期抵达加拿大(少于120个月)、既往治疗史以及人类免疫缺陷病毒(HIV)感染与耐多药结核病相关,其中年龄较小(35岁以下)、移民时间更近(少于24个月)、既往治疗史以及HIV感染在多变量分析中具有统计学意义。

结论

这些发现可能有助于该省的结核病临床医生在等待表型药物敏感性检测时制定初始经验性抗生素治疗方案,并协助决定是否要求进行快速分子药物敏感性检测。

相似文献

5
Isoniazid mono-resistant tuberculosis: Time to take it seriously.异烟肼单耐药结核病:是时候认真对待了。
Indian J Tuberc. 2019 Apr;66(2):247-252. doi: 10.1016/j.ijtb.2019.04.001. Epub 2019 Apr 9.

引用本文的文献

1
Isoniazid-resistant TB and associated factors in Ethiopia.埃塞俄比亚耐异烟肼结核病及其相关因素
Public Health Action. 2025 Jun 4;15(2):76-81. doi: 10.5588/pha.25.0002. eCollection 2025 Jun.

本文引用的文献

1
Tuberculosis in Canada, 2016.2016年加拿大的结核病情况
Can Commun Dis Rep. 2018 Mar 1;44(3-4):75-81. doi: 10.14745/ccdr.v44i34a01.
2
Tuberculosis drug resistance in Canada: 2017.2017年加拿大的结核病耐药情况
Can Commun Dis Rep. 2018 Nov 1;44(11):290-296. doi: 10.14745/ccdr.v44i11a04.
5
Multidrug-resistant tuberculosis: Treatment and outcomes of 93 patients.耐多药结核病:93例患者的治疗及转归
Can Respir J. 2015 Mar-Apr;22(2):97-102. doi: 10.1155/2015/359301. Epub 2014 Dec 10.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验